Your browser doesn't support javascript.
loading
Mast cells as a therapeutic target in myeloproliferative neoplasms.
Toledo, Marcelo A S; Chatain, Nicolas; Zenke, Martin; Koschmieder, Steffen.
Affiliation
  • Toledo MAS; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany. Electronic address: Marcelo.Szymanski@rwth-aachen.de.
  • Chatain N; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
  • Zenke M; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
  • Koschmieder S; Department of Hematology, Oncology, Hemostaseology, and Stem Cell Transplantation, Faculty of Medicine, RWTH Aachen University, Aachen, Germany; Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf (CIO ABCD), Aachen, Germany.
Trends Mol Med ; 28(11): 902-905, 2022 11.
Article in En | MEDLINE | ID: mdl-36064534

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis, Systemic / Myeloproliferative Disorders Limits: Humans Language: En Journal: Trends Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mastocytosis, Systemic / Myeloproliferative Disorders Limits: Humans Language: En Journal: Trends Mol Med Journal subject: BIOLOGIA MOLECULAR Year: 2022 Document type: Article Country of publication: United kingdom